HCPCS Level II code C9740 represents cystourethroscopy with insertion of transprostatic implants (4 or more). This endoscopic urologic procedure is used to address lower urinary tract obstruction by placing multiple implants within the prostate through a transurethral approach. Nationally, the code matters for surgical billing, facility planning, and coverage determinations as use of implantable technologies expands in benign prostatic hyperplasia and related conditions.

Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for the procedure, the typical sites of service where it is performed, and the common payer policies that affect coverage and claims handling for implant-based cystourethroscopy. The publication summarizes benchmark metrics where available, describes typical documentation and coding considerations tied to the service description, and flags areas where policy updates or coding guidance commonly arise. Data not available in the input is noted where applicable.